Pictet Asset Management (UK)’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$94.9M Sell
764,846
-74,871
-9% -$9.4M 0.1% 231
2021
Q1
$99.2M Sell
839,717
-80,330
-9% -$9.41M 0.12% 211
2020
Q4
$108M Buy
920,047
+4,518
+0.5% +$497K 0.14% 187
2020
Q3
$95.1M Buy
915,529
+147,595
+19% +$14.8M 0.15% 181
2020
Q2
$70.4M Buy
767,934
+112,618
+17% +$10.8M 0.12% 210
2020
Q1
$59.1M Buy
655,316
+39,685
+6% +$4.22M 0.13% 198
2019
Q4
$69.8M Buy
+615,631
New +$67.6M 0.12% 209
2015
Q1
Sell
-724,582
Closed -$52.3M 882
2014
Q4
$52.3M Buy
724,582
+73,427
+11% +$5.1M 0.23% 109
2014
Q3
$40.3M Buy
651,155
+18,700
+3% +$1.19M 0.19% 139
2014
Q2
$40.3M Buy
632,455
+143,300
+29% +$8.71M 0.19% 141
2014
Q1
$30.1M Sell
489,155
-130,700
-21% -$7.61M 0.15% 166
2013
Q4
$35.6M Sell
619,855
-8,200
-1% -$465K 0.18% 145
2013
Q3
$33.4M Buy
628,055
+11,200
+2% +$603K 0.19% 144
2013
Q2
$31.7M Buy
+616,855
New +$30.5M 0.18% 134

Other funds holding MDT

Pictet Asset Management (UK)'s MDT Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its Medtronic (MDT) stake by 8.9% in Q2 2021, selling an estimated $9.4M and leaving 764,846 shares worth $94.9M. The position accounts for 0.1% of the portfolio, ranked #231.

Pictet Asset Management (UK) first reported a position in MDT in Q2 2013 and has held it in 14 quarters since. The position peaked at $108M in Q4 2020. 2,003 funds tracked by Wall St. Rank hold MDT as of Q2 2021.

  • Pictet Asset Management (UK) held 764,846 shares of Medtronic worth $94.9M as of Q2 2021.
  • Pictet Asset Management (UK) sold 74,871 Medtronic shares in Q2 2021, an estimated $9.4M.
  • Medtronic made up 0.1% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #231 holding.
  • Pictet Asset Management (UK) first reported a position in Medtronic in Q2 2013 and has held it in 14 quarters since.
  • Pictet Asset Management (UK)'s Medtronic position peaked at $108M in Q4 2020.
  • 2,003 funds tracked by Wall St. Rank held Medtronic as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.